eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
Date: January 29, 2021
Company: eHealth, Inc.
Event: Entry into a binding term sheet for a private placement of 8% Convertible Preferred Stock with an affiliate of H.I.G. Capital.
Key Financial Metrics and Transaction Terms
- Transaction Size: $225,000,000 aggregate purchase price.
- Instrument: 2,250,000 shares of newly designated 8% Convertible Preferred Stock.
- Stated Value: $100 per share.
- Dividend Structure:
- Initial: 8% per annum, compounded semiannually, payable in kind (until June 30, 2023).
- Subsequent: 6% payable in kind and 2% payable in cash (beginning June 30, 2023).
- Conversion Price: Initial price of $90 per share of Common Stock, subject to a reset mechanism 121 days post-signing based on volume-weighted average price (capped between $50 and $90).
- Liquidity Covenants: Company must maintain minimum average liquidity of $125,000,000 (or $100,000,000 if stock price exceeds $125/share).
- Asset Coverage Ratio: Minimum 2x (Commissions Receivable / Accrued Value + Funded Indebtedness).
Material Changes and Conditions
This filing represents a material change in capital structure pending the execution of definitive documentation. The transaction is subject to Nasdaq approval and customary closing conditions. The filing does not provide comparative financial performance metrics (revenue, profit, cash flow) for the period; it focuses exclusively on the terms of the proposed financing.
Outlook, Risks, and Governance Implications
- Board Control: H.I.G. Capital receives the right to nominate one director. If liquidity or asset coverage covenants are breached, H.I.G. may appoint an additional director and gain approval rights over the annual budget, C-suite hiring/firing, and new senior debt.
- Repurchase Rights:
- Put Right: Holders may force repurchase after the sixth anniversary at 135% of Accrued Value or conversion value, whichever is greater.
- Change of Control: Triggers a repurchase right at 145% of Accrued Value or conversion value.
- Termination: Either party may terminate the term sheet 20 days after January 29, 2021, if definitive documentation is not executed.
- Risk Factors: The transaction is contingent on Nasdaq listing approval. Failure to meet liquidity covenants could result in significant loss of management autonomy.
Investor Verification Checklist
- Confirm execution of definitive documentation and Nasdaq listing approval.
- Verify the company's current liquidity position against the $125 million covenant threshold.
- Monitor the Common Stock price relative to the $90 conversion price and the $125 threshold for covenant adjustments.
- Review the impact of the 8% dividend accrual on future earnings per share (EPS) upon conversion.
- Assess the implications of H.I.G. Capital's potential board expansion rights if covenants are breached.